BofA Lowers Teladoc (TDOC) PT on Peer Multiple Compression, Soft Sensor Tower Trends

Teladoc Health Inc. (NYSE:TDOC) is one of the best single digit stocks to buy according to analysts. On January 27, Bank of America analyst Allen Lutz lowered the firm’s price target on Teladoc to $7 from $7.50 and maintained a Neutral rating. Lutz noted that Sensor Tower trends indicate Q4 2025 revenue may align with consensus but fall slightly below the midpoint of Teladoc’s own guidance, with the revised price target reflecting a compression in peer multiples.

Earlier on January 27, Goldman Sachs lowered its price target for Teladoc from $9 to $8 while keeping a Buy rating. The firm noted that MedTech and Healthcare IT stocks experienced a sharp decline between January 8 and 14, dropping ~3% and 11%, respectively, a movement that Goldman Sachs believes is largely disconnected from company fundamentals.

On January 9, Citi analyst Daniel Grosslight lowered the firm’s price target on Teladoc Health Inc. (NYSE:TDOC) from $10 to $9 and kept a Neutral rating as part of a 2026 outlook for the health tech and distribution sector. Grosslight noted that 2025 was a difficult year for the industry, with nearly a third of the group experiencing declines of more than 25%. However, the firm expressed cautious optimism regarding a potential recovery in 2026.

Teladoc Health Inc. (NYSE:TDOC) provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments.

While we acknowledge the potential of TDOC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.